Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

WuXi Biologics (2269)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.62 -0.10    -0.85%
03:59:53 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG970081173 
  • Volume: 27,472,447
  • Bid/Ask: 11.60 / 11.60
  • Day's Range: 11.52 - 11.80
WuXi Biologics 11.62 -0.10 -0.85%

WuXi Biologics is a component of the following Indices

 
See which major and sector indices this stock is a component of.
Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

 IndexLastHighLowChg.Chg. %Time
 Hang Seng18,053.9618,240.1317,968.37-281.36-1.53%04:00:00 
 CSI Overseas Mainland Enterprises2,743.982,743.982,743.980.000.00%19/06 
 HSI-Commercial & Industrial9,980.5110,107.699,914.71-182.93-1.80%03:59:58 
 Hang Seng HK 352,055.092,076.392,050.52-31.25-1.50%03:59:58 
 S&P/HKEX LC26,448.9626,646.8026,268.08-420.23-1.56%03:59:45 
 Hang Seng Comp I2,702.512,728.672,691.53-38.38-1.40%03:59:58 
 Hang Seng CLC1,656.241,672.051,648.50-24.61-1.46%03:59:58 
 TR China 50178.33180.23177.77-0.95-0.53%20/06 
 MSCI EM1,087.661,094.061,086.62-8.10-0.74%07:19:00 
 HS Healthcare2,150.452,173.712,146.30-22.83-1.05%03:59:58 
 Hang Seng Healthcare6,900.346,975.326,887.21-73.52-1.05%03:59:58 
 HS Hong Kong-Listed Biotech756.63765.09755.01-7.97-1.04%03:59:58 
 HS Composite LargeCap & MidCap2,845.172,872.512,832.97-40.75-1.41%03:59:58 
 HS Stock Connect Hong Kong2,712.722,740.552,702.79-38.17-1.39%03:59:58 
 HS Innovative Drug1,427.411,444.491,425.95-12.72-0.88%03:59:58 
 HS High Beta2,744.752,770.842,721.98-36.83-1.32%03:59:58 
 HS Equal Weighted1,076.571,091.321,074.41-20.09-1.83%03:59:58 
 HS Defensive Industries3,493.673,528.353,473.09-54.75-1.54%03:59:58 
 HS SCHK New Economy2,797.202,827.562,777.94-46.36-1.63%03:59:58 
 HS SCHK Healthcare1,665.551,683.261,661.26-17.81-1.06%03:59:56 
 HS Large-Mid Cap2,377.292,400.612,367.07-34.48-1.43%03:59:58 
 HSI ESG2,206.982,227.692,200.16-33.29-1.49%03:59:58 
 HS Stock Connect Biotech 503,048.593,072.573,035.36-18.74-0.61%03:59:58 
 HS SCHK HK Companies2,235.242,257.802,229.99-33.59-1.48%03:59:58 
 HS SCHK Innovative Drug Select1,144.511,158.551,142.56-10.38-0.90%03:59:58 
 HSI ESG Enhanced Select3,493.783,532.513,478.40-55.46-1.56%03:59:58 
 HS SCHK Innovative Drug1,631.961,650.831,629.77-15.10-0.92%03:59:58 
 HS Large-Mid Cap Quality Select2,810.702,839.692,798.73-44.94-1.57%03:59:58 
 HS Large-Mid Cap Value Select2,551.202,575.362,540.32-38.11-1.47%03:59:56 
 HSI Low Carbon4,563.594,610.144,540.09-70.70-1.53%03:59:58 
 HSI ESG Enhanced3,635.963,673.753,618.41-57.55-1.56%03:59:58 
 HS Large-Mid Cap Value Comprehensive2,525.902,549.992,515.43-37.67-1.47%03:59:58 
 HS Large-Mid Cap Low Size Select2,687.132,717.352,675.12-42.80-1.57%03:59:56 
 HS Large-Mid Cap Momentum Select3,089.503,118.433,077.20-44.09-1.41%03:59:58 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2269 Comments

Write your thoughts about WuXi Biologics
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Jun 09, 2022 2:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nomura Axes WUXI BIO TP to $95.75, Rating Buy
Surachet Lertsapsuree
Surachet Lertsapsuree Dec 15, 2021 2:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s happen?
JAME Megueni
VRAQ Dec 06, 2021 10:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
M Stanley Foresees WUXI BIO Shr Rise in 30 Days, Rated Overweight with $175 TP
JAME Megueni
VRAQ Jun 21, 2021 10:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Adds WUXI BIO TP to $167; Rated*** ***Buy
JAME Megueni
VRAQ Jun 20, 2021 10:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
C Suisse Hikes WUXI BIO TP to $158, Rated ***Outperform***
Christopher Koay
Christopher Koay Apr 23, 2021 12:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Goldman Sachs Increases TP to $131.4 Rated BUY ! 👍🏻
JAME Megueni
VRAQ Apr 13, 2021 3:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JPM Hikes WUXI BIO TP to $130; Rated ***Overweight***
JAME Megueni
VRAQ Mar 28, 2021 11:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nomura Chops WUXI BIO TP to $116.8, Rated ***Buy***
Christopher Koay
Christopher Koay Mar 15, 2021 4:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Definitely will back to 120 by end of this year. Company future is very good. Next factory to be setup to increase capacity expansion is ongoing till 2023. Stay tune for the extraordinary earning in the coning years. Surely a high growth positive cashflow company in China 👍🏻
JAME Megueni
VRAQ Mar 09, 2021 10:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa: WUXI BIO ( Share Correction Overdone Entails Bottom-fish Odds, Restated ***Buy***
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email